Potential clinical applications of BP 897, a partial dopamine D3 agonist

被引:0
|
作者
Schwartz, JC [1 ]
机构
[1] Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, Paris, France
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:68S / 69S
页数:2
相关论文
共 50 条
  • [1] Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor
    Wood, MD
    Boyfield, I
    Nash, DJ
    Jewitt, FR
    Avenell, KY
    Riley, GJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) : 47 - 51
  • [2] The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    Wicke, K
    Garcia-Ladona, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) : 85 - 90
  • [3] BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction
    Garcia-Ladona, FJ
    Cox, BF
    [J]. CNS DRUG REVIEWS, 2003, 9 (02): : 141 - 158
  • [4] The dopamine D3 receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats
    Aujla, H
    Beninger, RJ
    [J]. BEHAVIOURAL PHARMACOLOGY, 2005, 16 (03): : 181 - 186
  • [5] The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking
    Khaled, Maram A. T. M.
    Araki, Keyghobad Farid
    Li, Beth
    Coen, Kathleen M.
    Marinelli, Peter W.
    Varga, Jeno
    Gaal, Jozsef
    Le Foll, Bernard
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (02): : 181 - 190
  • [6] BP897, a "selective" dopamine D3 receptor partial agonist, has actions in addition to attenuation of D3 transmission in modulating locomotion induced by L-dopa in monoamine depleted rats.
    Visanji, NP
    Millan, MJ
    Brotchie, JM
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1132
  • [7] Intra-BLA or intra-NAc infusions of the dopamine D3 receptor partial agonist, BP 897, block intra-NAc amphetamine conditioned activity
    Aujla, H
    Beninger, RJ
    [J]. BEHAVIORAL NEUROSCIENCE, 2004, 118 (06) : 1324 - 1330
  • [8] Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats
    Vincent Vazquez
    Stéphanie Weiss
    Bruno Giros
    Marie-Pascale Martres
    Valérie Daugé
    [J]. Psychopharmacology, 2007, 193 : 475 - 486
  • [9] Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats
    Vazquez, Vincent
    Weiss, Stephanie
    Giros, Bruno
    Martres, Marie-Pascale
    Dauge, Valerie
    [J]. PSYCHOPHARMACOLOGY, 2007, 193 (04) : 475 - 486
  • [10] The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats
    Spiller, Krista
    Xi, Zheng-Xiong
    Peng, Xiao-Qing
    Newman, Amy H.
    Ashby, Charles R., Jr.
    Heidbreder, Christian
    Gaal, Jozsef
    Gardner, Eliot L.
    [J]. PSYCHOPHARMACOLOGY, 2008, 196 (04) : 533 - 542